While M&A activity has been mostly lackluster, this has not been the case in the pharma industry. The major players are trying to reposition themselves for changes in regulations, as well as patent expirations of mega drugs.
So, today we got another deal: Watson Pharmaceuticals (NYSE: WPI) agreed to purchase Arrow Group for $1.75 billion. The transaction will be paid in cash and stock.
The Richest Woman in the World: How Gina Rinehart Earns her Billions
Preserve Your Budget by Freezing Foods -- Savings Experiment

